SUPERIOR CLINICAL
TRIAL SITE
PERFORMANCE

Proven by more than 100 real trials,
PhESi selected sites consistently
enroll more patients

INNOVATIVE AND
ADAPTIVE STATISTICAL
MODELS

We built the models on top of
a large set of live data sources
well known to the industry

LARGEST CLINICAL
TRIAL INVESTIGATORS
DATABASE

489,536 unique investigator
sites across the world and
counting

LIVE CONNECTION
WITH INTERNATIONAL
DATA SOURCES

Significant portion of our over
65,000 data sources are updated
automatically in real time

INTEGRATED APPROACH
TO SHORTEN ENROLLMENT
CYCLE TIME

We assess all the drivers
and quantify opportunities to
shorten enrollment cycle

Pharmaceutical Pipeline Enhancement Strategies

We have the largest database, patent protected methods, and more importantly proven superior enrollment results from actual clinical trials, consistently.

Clinical Trial Services

Site Selection

Our site selection services are based on the largest investigator site performance database. Our site selection method is protected by a combination of patents and technic know-hows. Sites recommended by PhESi have provided superior enrollment results in over 100 clinical trials.

Process Improvement Support

We thrive to change the dynamic in industrial tradition of conducting business improvement initiatives: quantify potential opportunities that can be improved, recommend actions to realize the opportunities, measure the impact from implementation, and reward the people who contribute to the achievements.

Trial Feasibility Assessment

Our study feasibility analysis services reliably identify the potential challenges for clinical trials in planning, and allow our clients to proactively take action to mitigate risk. At the same time, our data-driven feasibility assessments reliably provide a leveled ground for all the stakeholders to communicate effectively.

PhESi News

Jonathan Peachey Joins PhESi as Head of Client Services

  • July 10, 2017

PhESi has announced the appointment of Jonathan Peachey as a member of the Board and Head of Client Services today.

Peachey has an outstanding track record of growing successful businesses in the life sciences industry, most recently as a Board Director and Head of Client Partnerships at Kinapse Ltd. Peachey has 25 years of industry experience, leading and delivering business transformation across Pharma R&D. His capabilities span strategy, business and IT transformation and performance improvement. Previously, Peachey has led IBM's EU Pharma R&D consulting practice and has held roles at GSK, BMS and Pfizer.

Breakthrough in Forecasting Enrollment Rate

  • January 21, 2015

In a recently published article Forecasting enrollment rate in clinical trials in APPLIED CLINICAL TRIALS online, Gen Li, President of PhESi, revealed that clinical trial enrollment rates can be expressed by simple mathematical formulas. For the first time, we can accurately forecast enrollment rate in clinical trials, and shorten enrollment cycle time through proactively designed actions.

Michael Tansey Joins PhESi

  • April 25, 2014

Michael Tansey, BSC MB ChB MD FFPM, former Chief Medical Officer of Pharmacia Corporation, has joined PhESi as a strategic partner.

Dr. Tansey is an established visionary leader in the pharmaceutical industry, with extensive international line management, strategic oversight, project development and process redesign experience. Joining forces between Dr. Tansey and PhESi will further enhance and expand our ability to serve our clients.

ClinicalTrial on Twitter